Literature DB >> 22727164

The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity.

Manbir Singh Sandhu, Vesselin Dimov, Arveen Kaur Sandhu, Ryan W Walters, Tammy Wichman, Thomas Casale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22727164     DOI： 10.1016/j.anai.2012.05.001

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  5 in total

1.  A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.

Authors:  Maryann Kaler; Amisha V Barochia; Nargues A Weir; Rosemarie A Cuento; Mario Stylianou; Mark J Roth; Armando C Filie; Ellen C Vaughey; Steven D Nathan; Stewart J Levine
Journal:  J Allergy Clin Immunol       Date:  2017-06-15       Impact factor: 10.793

2.  PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

Authors:  Asoka Banno; Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  Nucl Receptor Res       Date:  2017-12-11

3.  Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study.

Authors:  Seppo T Rinne; Laura C Feemster; Bridget F Collins; David H Au; Mark Perkins; Christopher L Bryson; Thomas G O'Riordan; Chuan-Fen Liu
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-03       Impact factor: 3.406

4.  Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study.

Authors:  Thanh T Hoang; Sinjini Sikdar; Cheng-Jian Xu; Mi Kyeong Lee; Jonathan Cardwell; Erick Forno; Medea Imboden; Ayoung Jeong; Anne-Marie Madore; Cancan Qi; Tianyuan Wang; Brian D Bennett; James M Ward; Christine G Parks; Laura E Beane-Freeman; Debra King; Alison Motsinger-Reif; David M Umbach; Annah B Wyss; David A Schwartz; Juan C Celedón; Catherine Laprise; Carole Ober; Nicole Probst-Hensch; Ivana V Yang; Gerard H Koppelman; Stephanie J London
Journal:  Eur Respir J       Date:  2020-09-03       Impact factor: 16.671

Review 5.  Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.

Authors:  Drishti Tiwari; Pawan Gupta
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.